Skip to content
Screener

Globus Medical GMED Reportable Segment — Business Combination, Acquisition-Related Cost, Expense

Similar metrics at other companies

OLP
OLPXReportable Segment — Business Combination, Acquisition-Related Cost, Expense
$7.4M
NSA
NSAReportable Segment — Business Combination, Acquisition-Related Cost, Expense
$811K-66.8%
APO
APOGReportable Segment — Business Combination, Acquisition-Related Cost, Expense
$800K+189%
Cronos Group logo
CRONReportable Segment — Business Combination, Acquisition-Related Cost, Expense
$581K+1,716%
Concentra Group Holdings Parent logo
CONReportable Segment — Business Combination, Acquisition-Related Cost, Expense
$219K-93.0%
Healthcare Realty Trust logo
HRMedial Outpatient Properties Segment — Business Combination, Acquisition-Related Cost, Expense
$937K-7.3%

Other financials

Income statement

See full
Revenue$789.6M+5.9%
Gross profit$548.2M+10.4%
Operating income$182.4M+140%
Net income$151.6M-25.3%
EPS (diluted)$1.10-26.2%

Balance sheet

See full
Cash & equivalents$507.7M+121%
Total debt$112.3M-7.6%
Total equity$4.8B+11.0%
Total assets$5.5B+10.6%

Cash flow

See full
Operating cash flow$209.7M+169%
CapEx$33.2M-28.8%
Free cash flow$176.6M+464%

Valuation

See full
Market cap$10.93B+52.9%
Enterprise value$10.54B+49.6%
P/E20.4×+0.4×
P/S3.5×+0.8×

Profitability

See full
Gross margin68.5%+5.8pp
Operating margin20.3%+9.6pp
Net margin17%+3.4pp
FCF margin24%+3.9pp

Returns & leverage

See full
Return on equity11.8%+3.2pp
Debt / equity0.0×
Current ratio4.6×+0.5×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationAcquisitionRelatedCosts.

The source filing: Globus Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054450
(in thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Selling, general and administrative employee-related cost(218,357)(237,372)(445,257)(426,353)
Selling, general and administrative other (c)(55,364)(59,258)(113,797)(104,881)
Provision for litigation(62)2,621(196)3,908
Acquisition-related costs(11,080)(33,155)(17,457)(34,213)
Amortization of intangibles(29,560)(30,189)(59,086)(58,991)
Other segment expenses (d)(13,827)(22,390)(29,100)(31,156)
Operating income/(loss)183,60376,881336,238174,598
Interest income/(expense), net7,07469312,5082,374

Item 1. Financial Statements

FAQ

What is Globus Medical's reportable segment — business combination, acquisition-related cost, expense?
Globus Medical (GMED) reported reportable segment — business combination, acquisition-related cost, expense of $11.08M in Q2 2026.
How has Globus Medical's reportable segment — business combination, acquisition-related cost, expense changed year-over-year?
Globus Medical's reportable segment — business combination, acquisition-related cost, expense decreased by 66.6% year-over-year, from $33.16M to $11.08M.
What does reportable segment — business combination, acquisition-related cost, expense mean?
Includes transaction-related costs such as legal, accounting, and advisory fees incurred during the acquisition of other businesses. These are typically non-recurring expenses associated with inorganic growth strategies.

Ask your AI about Globus Medical's reportable segment — business combination, acquisition-related cost, expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude